{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:40:22Z","timestamp":1778740822788,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#465687\/2014-8"],"award-info":[{"award-number":["#465687\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#400889\/2014-5"],"award-info":[{"award-number":["#400889\/2014-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#313602\/2019-0"],"award-info":[{"award-number":["#313602\/2019-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BRICS-STI","award":["#442351\/2017-8"],"award-info":[{"award-number":["#442351\/2017-8"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00436-022-07618-0","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T04:02:41Z","timestamp":1660622561000},"page":"2861-2874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vitro interaction of polyethylene glycol-block-poly(D,L-lactide) nanocapsule devices with host cardiomyoblasts and Trypanosoma cruzi-infective forms"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3015-1187","authenticated-orcid":false,"given":"Raoni Pais","family":"Siqueira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus Marques","family":"Milagre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Alice","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Tupinamb\u00e1","family":"Branquinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Karoline Vieira","family":"Torchelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"de Lana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Guimar\u00e3es Carvalho","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margareth Spangler","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Terezinha","family":"Bahia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0368-6090","authenticated-orcid":false,"given":"Vanessa Carla Furtado","family":"Mosqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"7618_CR1","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.msec.2017.03.266","volume":"77","author":"JP Abriata","year":"2017","unstructured":"Abriata JP, Eloy JO, Riul TB et al (2017) Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection. Mater Sci Eng C 77:1196\u20131203. https:\/\/doi.org\/10.1016\/j.msec.2017.03.266","journal-title":"Mater Sci Eng C"},{"key":"7618_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF00931809","volume":"75","author":"TC Ara\u00fajo-Jorge","year":"1989","unstructured":"Ara\u00fajo-Jorge TC, Sampaio EP, De Souza W, Meirelles MN (1989) Trypanosoma cruzi: the effect of variations in experimental conditions on the levels of macrophage infection in vitro. Parasitol Res 75:257\u2013263. https:\/\/doi.org\/10.1007\/BF00931809","journal-title":"Parasitol Res"},{"key":"7618_CR3","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1517\/13543784.2014.922952","volume":"23","author":"MT Bahia","year":"2014","unstructured":"Bahia MT, De Figueiredo Diniz LDF, Mosqueira VCF (2014) Therapeutical approaches under investigation for treatment of Chagas disease. Expert Opin Investig Drugs 23:1225\u20131237. https:\/\/doi.org\/10.1517\/13543784.2014.922952","journal-title":"Expert Opin Investig Drugs"},{"key":"7618_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2019.105057","author":"E Barrias","year":"2019","unstructured":"Barrias E, Reignault L, de Carvalho TMU, de Souza W (2019) Clathrin coated pit dependent pathway for Trypanosoma cruzi internalization into host cells. Acta Trop. https:\/\/doi.org\/10.1016\/j.actatropica.2019.105057","journal-title":"Acta Trop"},{"key":"7618_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jconrel.2013.06.014","volume":"170","author":"G Bastiat","year":"2013","unstructured":"Bastiat G, Pritz CO, Roider C et al (2013) A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging. J Control Release 170:334\u2013342. https:\/\/doi.org\/10.1016\/j.jconrel.2013.06.014","journal-title":"J Control Release"},{"key":"7618_CR6","doi-asserted-by":"publisher","unstructured":"Batista DGJ, Silva CF, Mota RA, Costa LC, Meirelles MNL, Meuser-Batista M, Soeiro MNC (2006) Trypanosoma cruzi modulates the expression of Rabs and alters the endocytosis in mouse cardiomyocytes in vitro. Histochem Cytochem 54(6):605\u2013614. https:\/\/doi.org\/10.1369\/jhc.5A6654.2005","DOI":"10.1369\/jhc.5A6654.2005"},{"key":"7618_CR7","doi-asserted-by":"publisher","unstructured":"Batista CM, Kessler RL, Eger I, Soares MJ (2015) Trypanosoma cruzi intracellular amastigotes isolated by nitrogen decompression are capable of endocytosis and cargo storage in reservosomes. PLoS One.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0130165","DOI":"10.1371\/journal.pone.0130165"},{"key":"7618_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fcell.2020.00396","volume":"8","author":"MF Batista","year":"2020","unstructured":"Batista MF, N\u00e1jera CA, Meneghelli I, Bahia D (2020) The parasitic intracellular lifestyle of trypanosomatids: parasitophorous vacuole development and survival. Front Cell Dev Biol 8:396. https:\/\/doi.org\/10.3389\/fcell.2020.00396","journal-title":"Front Cell Dev Biol"},{"key":"7618_CR9","doi-asserted-by":"publisher","unstructured":"Branquinho RT, De Mello CGC, Oliveira MT, et al (2020) Lychnopholide in poly(D,L-lactide)-block-polyethylene glycol nanocapsules cures infection with a drug-resistant Trypanosoma cruzi strain at acute and chronic phases. Antimicrob Agents Chemother 64.\u00a0https:\/\/doi.org\/10.1128\/AAC.01937-19","DOI":"10.1128\/AAC.01937-19"},{"key":"7618_CR10","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1128\/AAC.00617-13","volume":"58","author":"RT Branquinho","year":"2014","unstructured":"Branquinho RT, Mosqueira VCF, De Oliveira-Silva JCV et al (2014) Sesquiterpene lactone in nanostructured parenteral dosage form is efficacious in experimental Chagas disease. Antimicrob Agents Chemother 58:2067\u20132075. https:\/\/doi.org\/10.1128\/AAC.00617-13","journal-title":"Antimicrob Agents Chemother"},{"key":"7618_CR11","doi-asserted-by":"publisher","unstructured":"Branquinho RT, Pound-Lana G, Marques Milagre M, et al (2017) Increased body exposure to new anti-trypanosomal through nanoencapsulation. Sci Rep 7.\u00a0https:\/\/doi.org\/10.1038\/s41598-017-08469-x","DOI":"10.1038\/s41598-017-08469-x"},{"key":"7618_CR12","doi-asserted-by":"publisher","unstructured":"Brosson S, Fontaine F, Vermeersch M, et al (2016) Specific endocytosis blockade of Trypanosoma cruzi exposed to a poly-LAcNAc binding lectin suggests that lectin-sugar interactions participate to receptor-mediated endocytosis. PLoS One.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0163302","DOI":"10.1371\/journal.pone.0163302"},{"key":"7618_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molbiopara.2014.01.002","volume":"193","author":"MCO Campos","year":"2014","unstructured":"Campos MCO, Leon LL, Taylor MC, Kelly JM (2014) Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanisms can act in concert. Mol Biochem Parasitol 193:17\u201319. https:\/\/doi.org\/10.1016\/j.molbiopara.2014.01.002","journal-title":"Mol Biochem Parasitol"},{"key":"7618_CR14","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1128\/AAC.00178-16","volume":"60","author":"CGC De Mello","year":"2016","unstructured":"De Mello CGC, Branquinho RT, Oliveira MT et al (2016) Efficacy of lychnopholide polymeric nanocapsules after oral and intravenous administration in murine experimental Chagas disease. Antimicrob Agents Chemother 60:5215\u20135222. https:\/\/doi.org\/10.1128\/AAC.00178-16","journal-title":"Antimicrob Agents Chemother"},{"key":"7618_CR15","doi-asserted-by":"crossref","unstructured":"De Souza W, De Carvalho TMU, Barrias ES (2010) Review on Trypanosoma cruzi: host cell interaction. Int J Cell Biol","DOI":"10.1155\/2010\/295394"},{"key":"7618_CR16","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.2174\/092986712802884222","volume":"19","author":"S Espuelas","year":"2012","unstructured":"Espuelas S, Plano D, Nguewa P et al (2012) Innovative lead compounds and formulation strategies as newer kinetoplastid therapies. Curr Med Chem 19:4259\u20134288. https:\/\/doi.org\/10.2174\/092986712802884222","journal-title":"Curr Med Chem"},{"key":"7618_CR17","doi-asserted-by":"publisher","unstructured":"Fessi H, Puisieux F, Devissaguet JP, et al (1989) Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 55.\u00a0https:\/\/doi.org\/10.1016\/0378-5173(89)90281-0","DOI":"10.1016\/0378-5173(89)90281-0"},{"key":"7618_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.actatropica.2017.02.019","volume":"170","author":"GA Islan","year":"2017","unstructured":"Islan GA, Dur\u00e1n M, Cacicedo ML et al (2017) Nanopharmaceuticals as a solution to neglected diseases: is it possible? Acta Trop 170:16\u201342. https:\/\/doi.org\/10.1016\/j.actatropica.2017.02.019","journal-title":"Acta Trop"},{"key":"7618_CR19","doi-asserted-by":"publisher","unstructured":"Leite EA, Grabe-Guimar\u00e3es A, Guimar\u00e3es HN et al (2007) Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices. Life Sci 80(14):1327\u20131334. https:\/\/doi.org\/10.1016\/j.lfs.2006.12.019","DOI":"10.1016\/j.lfs.2006.12.019"},{"key":"7618_CR20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3389\/fpubh.2019.00166","volume":"115","author":"KCF Lidani","year":"2019","unstructured":"Lidani KCF, Andrade FA, Bavia L et al (2019) Chagas disease: from discovery to a worldwide health problem. Front Public Health. 2;7:166. https:\/\/doi.org\/10.3389\/fpubh.2019.00166","journal-title":"Circulation"},{"key":"7618_CR21","doi-asserted-by":"crossref","unstructured":"Marin-Neto JA, Cunha-Neto E, Maciel BC, Sim\u00f5es MV (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115:1109\u20131123","DOI":"10.1161\/CIRCULATIONAHA.106.624296"},{"key":"7618_CR22","doi-asserted-by":"publisher","unstructured":"Mazzeti AL, Oliveira LT, Gon\u00e7alves KR, et al (2020) Benznidazole self-emulsifying delivery system: a novel alternative dosage form for Chagas disease treatment. Eur J Pharm Sci 145 https:\/\/doi.org\/10.1016\/j.ejps.2020.105234","DOI":"10.1016\/j.ejps.2020.105234"},{"key":"7618_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/jac\/47.1.101","volume":"47","author":"J Molina","year":"2001","unstructured":"Molina J (2001) Cure of experimental Chagas\u2019 disease by the bis-triazole DO870 incorporated into \u201cstealth\u201d polyethyleneglycol-polylactide nanospheres. J Antimicrob Chemother 47:101\u2013104. https:\/\/doi.org\/10.1093\/jac\/47.1.101","journal-title":"J Antimicrob Chemother"},{"key":"7618_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2217\/nnm.14.185","volume":"10","author":"MJ Morilla","year":"2015","unstructured":"Morilla MJ, Romero EL (2015) Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis. Nanomedicine 10:465\u2013481. https:\/\/doi.org\/10.2217\/nnm.14.185","journal-title":"Nanomedicine"},{"key":"7618_CR25","doi-asserted-by":"publisher","unstructured":"Morillo CA, Marin-Neto JA, Avezum A, et al (2015) Randomized trial of benznidazole for chronic Chagas\u2019 cardiomyopathy. N Engl J Med.\u00a0https:\/\/doi.org\/10.1056\/nejmoa1507574","DOI":"10.1056\/nejmoa1507574"},{"key":"7618_CR26","doi-asserted-by":"publisher","unstructured":"Mosqueira VCF, Legrand P, Gulik A, et al (2001a) Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials.\u00a0https:\/\/doi.org\/10.1016\/S0142-9612(01)00043-6","DOI":"10.1016\/S0142-9612(01)00043-6"},{"key":"7618_CR27","doi-asserted-by":"publisher","unstructured":"Mosqueira VCF, Legrand P, Morgat JL, et al (2001b) Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm Res.\u00a0https:\/\/doi.org\/10.1023\/A:1012248721523","DOI":"10.1023\/A:1012248721523"},{"key":"7618_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.eurpolymj.2017.03.028","volume":"90","author":"G Pound-Lana","year":"2017","unstructured":"Pound-Lana G, Rabanel JM, Hildgen P, Mosqueira VCF (2017) Functional polylactide via ring-opening copolymerisation with allyl, benzyl and propargyl glycidyl ethers. Eur Polym J 90:344\u2013353. https:\/\/doi.org\/10.1016\/j.eurpolymj.2017.03.028","journal-title":"Eur Polym J"},{"key":"7618_CR29","doi-asserted-by":"publisher","first-page":"6407","DOI":"10.2147\/IJN.S206109","volume":"14","author":"CQ Quezada","year":"2019","unstructured":"Quezada CQ, Azevedo CS, Charneau S et al (2019) Advances in nanocarriers as drug delivery systems in Chagas disease. Int J Nanomedicine 14:6407\u20136424. https:\/\/doi.org\/10.2147\/IJN.S206109","journal-title":"Int J Nanomedicine"},{"key":"7618_CR30","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Toloza G, Ferreira A (2017) Trypanosoma cruzi evades the complement system as an efficient strategy to survive in the mammalian host: the specific roles of host\/parasite molecules and Trypanosoma cruzi calreticulin. Front Microbiol 8","DOI":"10.3389\/fmicb.2017.01667"},{"key":"7618_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1590\/s0074-02762009000900021","volume":"104","author":"A Rassi","year":"2009","unstructured":"Rassi A, Rassi A, Marin-Neto JA (2009) Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz 104:152\u2013158. https:\/\/doi.org\/10.1590\/s0074-02762009000900021","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"7618_CR32","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1021\/acs.molpharmaceut.6b01034","volume":"14","author":"M Rol\u00f3n","year":"2017","unstructured":"Rol\u00f3n M, Serrano DR, Lalatsa A et al (2017) Engineering oral and parenteral amorphous amphotericin B formulations against experimental Trypanosoma cruzi infections. Mol Pharm 14:1095\u20131106. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b01034","journal-title":"Mol Pharm"},{"key":"7618_CR33","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.4269\/ajtmh.16-0761","volume":"97","author":"PA Sales","year":"2017","unstructured":"Sales PA, Molina I, Murta SMF et al (2017) Experimental and clinical treatment of Chagas disease: a review. Am J Trop Med Hyg 97:1289\u20131303","journal-title":"Am J Trop Med Hyg"},{"key":"7618_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00436-010-1725-1","volume":"106","author":"J Saraiva","year":"2010","unstructured":"Saraiva J, Lira AAM, Esperandim VR et al (2010) (-)-Hinokinin-loaded poly(d, l-lactide-co-glycolide) microparticles for Chagas disease. Parasitol Res 106:703\u2013708. https:\/\/doi.org\/10.1007\/s00436-010-1725-1","journal-title":"Parasitol Res"},{"issue":"1","key":"7618_CR35","doi-asserted-by":"publisher","first-page":"e30356","DOI":"10.1371\/journal.pone.0030356","volume":"7","author":"CF Silva","year":"2012","unstructured":"Silva CF, Batista DG, Oliveira GM et al (2012) In vitro and in vivo investigation of the efficacy of arylimidamide DB1831 and its mesylated salt form\u2013DB1965\u2013against Trypanosoma cruzi infection. PLoS One 7(1):e30356. https:\/\/doi.org\/10.1371\/journal.pone.0030356","journal-title":"PLoS One"},{"issue":"12","key":"7618_CR36","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.bcp.2007.03.020","volume":"73","author":"CF Silva","year":"2007","unstructured":"Silva CF, Batista MM, Mota RA et al (2007) Activity of \u201creversed\u201d diamidines against Trypanosoma cruzi \u201cin vitro.\u201d Biochem Pharmacol 73(12):1939\u20131946. https:\/\/doi.org\/10.1016\/j.bcp.2007.03.020 (Epub 2007 Mar 24 PMID: 17462605)","journal-title":"Biochem Pharmacol"},{"key":"7618_CR37","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/cyto.a.22853","volume":"91","author":"S Snipstad","year":"2017","unstructured":"Snipstad S, Hak S, Baghirov H et al (2017) Labeling nanoparticles: dye leakage and altered cellular uptake. Cytom Part A 91:760\u2013766. https:\/\/doi.org\/10.1002\/cyto.a.22853","journal-title":"Cytom Part A"},{"key":"7618_CR38","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1128\/AAC.00070-13","volume":"57","author":"MN Soeiro","year":"2013","unstructured":"Soeiro MN, de Souza EM, da Silva CF et al (2013) In vitro and in vivo studies of the antiparasitic activity of sterol 14\u03b1-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi. Antimicrob Agents Chemother 57:4151\u20134163. https:\/\/doi.org\/10.1128\/AAC.00070-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"7618_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000067307","volume":"70","author":"MN Soeiro","year":"2002","unstructured":"Soeiro MN, Mota RA, Batista DG et al (2002) Trypanosoma cruzi infection impairs the endocytosis of zymosan A by cardiomyocytes. Pathobiology 70(2):69\u201375. https:\/\/doi.org\/10.1159\/000067307 (PMID: 12476031)","journal-title":"Pathobiology"},{"key":"7618_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/1381612023396276","volume":"8","author":"W Souza","year":"2002","unstructured":"Souza W (2002) Basic cell biology of Trypanosoma cruzi. Curr Pharm Des 8:269\u2013285. https:\/\/doi.org\/10.2174\/1381612023396276","journal-title":"Curr Pharm Des"},{"issue":"19","key":"7618_CR41","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1111\/bph.15186","volume":"177","author":"ACM Souza","year":"2020","unstructured":"Souza ACM, Grabe-Guimar\u00e3es A, Cruz JDS et al (2020) Mechanisms of artemether toxicity on single cardiomyocytes and protective effect of nanoencapsulation. Br J Pharmacol 177(19):4448\u20134463. https:\/\/doi.org\/10.1111\/bph.15186","journal-title":"Br J Pharmacol"},{"key":"7618_CR42","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.2147\/IJN.S133708","volume":"12","author":"P\u00c1 Sp\u00f3sito","year":"2017","unstructured":"Sp\u00f3sito P\u00c1, Mazzeti AL, de Faria C, O, et al (2017) Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity. Int J Nanomedicine 12:3785\u20133799. https:\/\/doi.org\/10.2147\/IJN.S133708","journal-title":"Int J Nanomedicine"},{"key":"7618_CR43","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1017\/S0031182018000197","volume":"145","author":"LD Tessarolo","year":"2018","unstructured":"Tessarolo LD, De Menezes RRPPB, Mello CP et al (2018) Nanoencapsulation of benznidazole in calcium carbonate increases its selectivity to Trypanosoma cruzi. Parasitology Mineral Mag 145:1191\u20131198. https:\/\/doi.org\/10.1017\/S0031182018000197","journal-title":"Parasitology Mineral Mag"},{"key":"7618_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejps.2018.08.024","volume":"124","author":"IC Trindade","year":"2018","unstructured":"Trindade IC, Pound-Lana G, Pereira DGS et al (2018) Mechanisms of interaction of biodegradable polyester nanocapsules with non-phagocytic cells. Eur J Pharm Sci 124:89\u2013104. https:\/\/doi.org\/10.1016\/j.ejps.2018.08.024","journal-title":"Eur J Pharm Sci"},{"key":"7618_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jsb.2016.07.018","volume":"196","author":"JC Vidal","year":"2016","unstructured":"Vidal JC, de Alcantara CL, de Souza W, Cunha-e-Silva NL (2016) Loss of the cytostome-cytopharynx and endocytic ability are late events in Trypanosoma cruzi metacyclogenesis. J Struct Biol 196:319\u2013328. https:\/\/doi.org\/10.1016\/j.jsb.2016.07.018","journal-title":"J Struct Biol"},{"key":"7618_CR46","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s13063-019-3423-3","volume":"20","author":"JC Villar","year":"2019","unstructured":"Villar JC, Herrera VM, P\u00e9rez Carre\u00f1o JG et al (2019) Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): Study protocol for a randomised controlled trial. Trials 20:431. https:\/\/doi.org\/10.1186\/s13063-019-3423-3","journal-title":"Trials"},{"key":"7618_CR47","unstructured":"WHO (2018) Chagas disease in the Americas: a review of the current public health situation and a vision for the future. Rep Conclusions Recomentation"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07618-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-022-07618-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07618-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T05:18:56Z","timestamp":1662787136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-022-07618-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["7618"],"URL":"https:\/\/doi.org\/10.1007\/s00436-022-07618-0","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"assertion":[{"value":"7 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}